Homepage
Medication Guide
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy for IDH1-mutant acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma. Its proper acquisition and standardized administration directly im...
501
Tuesday, December 16th, 2025, 13:09
Adverse Effects of Finerenone
Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist that plays an important role in the treatment of patients with chronic kidney disease complicated by type 2 diabetes mellitus ...
502
Tuesday, December 16th, 2025, 11:24
What Are the Precautions for Finerenone Administration?
Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist (nsMRA) that exhibits significant clinical value in the treatment of chronic kidney disease associated with type 2 diabetes me...
501
Tuesday, December 16th, 2025, 10:56
Dosage and Administration, Recommended Dose of Finerenone
As a novel non-steroidal mineralocorticoid receptor antagonist (nsMRA), finerenone demonstrates significant value in the treatment of chronic kidney disease complicated with type 2 diabetes mellitus, ...
501
Tuesday, December 16th, 2025, 10:54
What Are the Indications for Finerenone?
Finerenone is a novel non-steroidal mineralocorticoid receptor antagonist. By precisely inhibiting aldosterone- and cortisol-mediated fibrosis and inflammatory responses in the kidneys and cardiovascu...
500
Tuesday, December 16th, 2025, 10:44
What Are the Purchase Channels for Finerenone?
The significance of finerenone in the treatment of chronic kidney disease (CKD) complicated with type 2 diabetes mellitus (T2DM) and specific heart failure is increasingly prominent. How to obtain the...
501
Tuesday, December 16th, 2025, 10:38
What are the Indications of Valcyte?
Valcyte is an important antiviral drug, with valganciclovir as its active ingredient. As a prodrug of ganciclovir, it has a specific clinical application scope and strict medication standards.What are...
507
Tuesday, December 16th, 2025, 10:24
What Are the Medication Precautions for Lorlatinib (Lorviqua)?
Lorlatinib (Lorviqua) is a third-generation ALK inhibitor that has demonstrated favorable efficacy in the treatment of ALK-positive non-small cell lung cancer (NSCLC). To ensure treatment effectivenes...
501
Monday, December 15th, 2025, 15:00
What Are the Indications for Mobocertinib (Exkivity)?
Mobocertinib (Exkivity) is a new-generation EGFR inhibitor that provides an important treatment option for patients with specific mutations. As an innovative drug approved in the United States in 2021...
502
Monday, December 15th, 2025, 14:28
What Are the Purchase Channels for Mobocertinib (Exkivity)?
Mobocertinib (Exkivity) is a targeted drug used for the treatment of advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. With its increasingly widespread clinical applic...
501
Monday, December 15th, 2025, 14:20
4 / 184
1832 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved